Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Bart F. Werbrouck, Walter J. Pauwels & Jan L. De Bleecker. (2008) A case of 5-fluorouracil-induced peripheral neuropathy. Clinical Toxicology 46:3, pages 264-266.
Read now
Read now
Articles from other publishers (28)
Aasems Jacob, Janeesh Sekkath Veedu, Insija Selene, Rishi Raj, Lakshmi Kannan & Reema Patel. (2022) Case report: Uridine triacetate in the management of delayed onset 5-fluorouracil toxicity: A case report and review of literature. Frontiers in Pharmacology 13.
Crossref
Crossref
Denise Leung, Moh'd Khushman & Larry Junck. 2022. Neurological Complications of Systemic Cancer and Antineoplastic Therapy. Neurological Complications of Systemic Cancer and Antineoplastic Therapy
365
386
.
Gianfranco Natale & Guido Bocci. 2019. Brain and Heart Dynamics. Brain and Heart Dynamics
1
25
.
Gianfranco Natale & Guido Bocci. 2020. Brain and Heart Dynamics. Brain and Heart Dynamics
765
789
.
Muhammad W. Saif. (2019) Capecitabine-induced cerebellar toxicity and TYMS pharmacogenetics. Anti-Cancer Drugs 30:4, pages 431-434.
Crossref
Crossref
Mira Zurayk, Yi-Kong Keung, David Yu & Eddie HL Hu. (2017) Successful use of uridine triacetate (Vistogard) three weeks after capecitabine in a patient with homozygous dihydropyrimidine dehydrogenase mutation: A case report and review of the literature. Journal of Oncology Pharmacy Practice 25:1, pages 234-238.
Crossref
Crossref
. 2016. Meyler's Side Effects of Drugs. Meyler's Side Effects of Drugs
382
388
.
O. Sedlaczek, C. Grüllich, M. Röthke, H.-P. Schlemmer & H.-U. Kauczor. (2013) Organtoxizität medikamentöser TumortherapienOrgan toxicity of medicinal tumor therapy. Der Radiologe 53:4, pages 329-335.
Crossref
Crossref
Sandeep Kumar, Caroline Aninat, Grégoire Michaux & Fabrice Morel. (2010) Anticancer drug 5-fluorouracil induces reproductive and developmental defects in Caenorhabditis elegans. Reproductive Toxicology 29:4, pages 415-420.
Crossref
Crossref
Kate Scatchard & Siow Ming Lee. 2010. Neuro-Oncology. Neuro-Oncology
352
371
.
. 2010. Meyler's Side Effects of Drugs in Cancer and Immunology. Meyler's Side Effects of Drugs in Cancer and Immunology
1
229
.
Laura Sempere & Rodrigo Jover. (2008) Nuevas perspectivas en la predicción de la respuesta a la quimioterapia en el cáncer colorrectal. Gastroenterología y Hepatología 31:9, pages 580-586.
Crossref
Crossref
Michael J. Glantz & John W. Conlee. 2009. Cognition and Cancer. Cognition and Cancer
156
169
.
Sean A. Grimm & Lisa M. Deangelis. 2008. Neurology and General Medicine. Neurology and General Medicine
523
545
.
V. Formica, A. Leary, D. Cunningham & Y. J. Chua. (2005) 5-Fluorouracil can cross brain–blood barrier and cause encephalopathy: should we expect the same from capecitabine? A case report on capecitabine-induced central neurotoxicity progressing to coma. Cancer Chemotherapy and Pharmacology 58:2, pages 276-278.
Crossref
Crossref
. 2006. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions
1407
1419
.
Hanneke W.M. van Laarhoven, Cornelis J.A. Punt, Yvonne J.L. Kamm & Arend Heerschap. (2005) Monitoring fluoropyrimidine metabolism in solid tumors with in vivo 19F magnetic resonance spectroscopy. Critical Reviews in Oncology/Hematology 56:3, pages 321-343.
Crossref
Crossref
N. Mémain, J.-F. Angellier, E. Obadia, E. Angellier, R. Chelha & R. Couprie. (2005) Encéphalopathie aiguë fatale secondaire à un traitement par 5-fluoro-uracile. La Presse Médicale 34:21, pages 1637-1640.
Crossref
Crossref
M. Wasif Saif, Tina E. Wood, Philip J. McGee & Robert B. Diasio. (2004) Peripheral neuropathy associated with capecitabine. Anti-Cancer Drugs 15:8, pages 767-771.
Crossref
Crossref
Mika Endo, Masanori Miwa, Hiroyuki Eda, Masako Ura, Hiromi Tanimura, Tohru Ishikawa, Taeko Miyazaki-Nose, Kazuo Hattori, Nobuo Shimma, Hisafumi Yamada-Okabe & Hideo Ishitsuka. (2003) Augmentation of the antitumor activity of capecitabine by a tumor selective dihydropyrimidine dehydrogenase inhibitor, RO0094889. International Journal of Cancer 106:5, pages 799-805.
Crossref
Crossref
Deborah T. Blumenthal & Richard H. Wheeler. 2003. Cancer Neurology in Clinical Practice. Cancer Neurology in Clinical Practice
405
415
.
Lie Kuo Liem, Lina Hui Lin Choong & Keng Thye Woo. (2002) Porous graphitic carbon shows promise for the rapid screening partial DPD deficiency in lymphocyte dihydropyrimidine dehydrogenase in Chinese, Indian and Malay in Singapore by using semi-automated HPLC-radioassay. Clinical Biochemistry 35:3, pages 181-187.
Crossref
Crossref
Doreen Dobritzsch, Stefano Ricagno, Gunter Schneider, Klaus D. Schnackerz & Ylva Lindqvist. (2002) Crystal Structure of the Productive Ternary Complex of Dihydropyrimidine Dehydrogenase with NADPH and 5-Iodouracil. Journal of Biological Chemistry 277:15, pages 13155-13166.
Crossref
Crossref
Seung Seog Ki, Jin Mo Jeong, Seong Ho Kim, Sook Hyang Jeong, Jin Hyuk Lee, Chul Ju Han, You Cheol Kim, Jhin Oh Lee & Young Joon Hong. (2002) A Case of Neurotoxicity Following 5 - Fluorouracil - based Chemotherapy. The Korean Journal of Internal Medicine 17:1, pages 73-77.
Crossref
Crossref
Sharon J. Gardiner, Evan J. Begg & Bridget A. Robinson. (2012) The Effect of Dihydropyrimidine Dehydrogenase Deficiency on Outcomes with Fluorouracil. Adverse Drug Reactions and Toxicological Reviews 21:1-2, pages 1-16.
Crossref
Crossref
M Wasif Saif, Richard H Wilson, Nancy Harold, Bruce Keith, David S Dougherty & Jean L Grem. (2001) Peripheral neuropathy associated with weekly oral 5-fluorouracil, leucovorin and eniluracil. Anti-Cancer Drugs 12:6, pages 525-531.
Crossref
Crossref
Federico Innocenti, Lalitha Iyer & Mark J. Ratain. (2000) Pharmacogenetics. Clinical Pharmacokinetics 39:5, pages 315-325.
Crossref
Crossref
Andrew Stanley. 2000.
476
493
.